Foremost is the recommendation for collaboration across healthcare, social services, and the education and voluntary sectors to establish a local autism strategy group in each community. This group should ensure that early recognition, referral, and diagnosis of autism are well coordinated and guided by principles of evidence based practice and family centred care. It would also be responsible for streamlining the assessment process to minimise delays and ensure timely access to support and intervention services. It is recommended that the care pathway includes focused developmental surveillance for signs and symptoms of autism by community practitioners, and a single point of access for referral to a specialist team, with diagnostic assessments initiated within three months of referral.
The guidelines also recommend that surveillance for autism take account of a young person's overall development level. Signs and symptoms of possible autism are listed for children of preschool, primary school, and secondary school ages or equivalent mental ages. Thus, in contrast to previous practice guidelines, which focus almost exclusively on early detection, the NICE guidelines emphasise the diverse clinical presentation of this disorder across the developmental spectrum. The guidelines also note that specific subgroups of young people with autism (girls, children with severe intellectual disabilities, and, conversely, children who are more intellectually or verbally able) often experience delays in diagnosis so require special vigilance. 3 In addition, signs and symptoms of autism may be masked (for example, by coping mechanisms and environmental supports) in young people who present at an older age.
Considerable guidance is given about the initial decision to refer a young person for diagnostic assessment. Although some scenarios warrant immediate referral to the specialist team (such as language or social regression in a child younger than 3 years), it is recommended that several factors are considered when making referral decisions. These include the severity and functional impact of apparent signs and symptoms; the level of parental concern (and the concerns of the young person); and the presence of specific factors associated with increased risk of autism, including a positive family history (risk to siblings was recently reported to be as high as 19%). 4 Screening tools are regarded as a useful adjunct to gathering information about autism related behaviours, but caution is advised on using screening cut-off points as the sole basis for referral. This is a major point of departure from the American Academy of Pediatrics guidelines in the United States, 5 and it is likely to stimulate further debate on the current evidence base for autism screening. 6 7 Similarly, the NICE guidelines put more emphasis on the composition of the specialist team and the essential components of the diagnostic assessment than on the use of specific diagnostic tools. The minimum core team should consist of a paediatrician or a child and adolescent psychiatrist (or both), clinical or educational psychologist (or both), and speech and language therapist, with access to other health professionals either as part of the specialist team or through additional referral. The diagnostic assessment should include a thorough developmental history and enquiry about symptoms of autism, interactive assessment with the young person to assess his or her social communication skills and behaviours, and careful physical examination to identify associated medical conditions. The assessment should lead not only to determination of a diagnosis but also the establishment of a developmental profile. This should include factors that might affect day to day 
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functioning and social participation, such as intellectual ability, language and communication skills, adaptive behaviour, physical health, nutritional status, and behaviour. Thus, the assessment should clarify not only symptoms and impairment but also functioning and participation. This is consistent with the current international classification of functioning, disability and health (ICF) framework, 8 and it is relevant to setting priorities for intervention. The specialist team must also clearly and compassionately communicate the assessment findings, with an emphasis on ensuring that families are informed about autism, its implications for the young person's development and functioning, and the options for accessing support and services.
No routine medical investigations were recommended for young people with newly diagnosed autism. Specifically, genetic testing should be reserved for children with specific dysmorphic features, congenital anomalies, or intellectual delay. It is recommended that before implementing array-comparative genomic hybridisation testing on a routine basis for children with autism, clinicians need a better understanding of its diagnostic yield than is available from the current literature (particularly in children who do not have an intellectual disability). The authors argue that it is essential to identify potential negative consequences that may result from routine testing, particularly related to the identification of genetic variants of unknown clinical relevance. 9 Implementation of some of these recommendations (particularly timelines for assessment and the establishment of a local autism team in each community) may strain available resources and require additional strategies for professional training and mentorship. However, the guidelines play an essential role in establishing clear comprehensive evidence based standards for quality care for young people with autism, who have historically experienced substantial delays in diagnosis. 3 The guidelines move the discussion from the level of particular symptoms or the selection of particular diagnostic tests to advocating for better health system strategies, including closer partnerships between service sectors, community practitioners, autism specialists, and, indeed, families. This may ultimately have the greatest impact on promoting earlier diagnosis for people across the autism spectrum and improving family experience, although further evaluation of these important outcomes over time will be needed.
